Dare Bioscience, Inc. (NASDAQ:DARE) filed a Form 8-K with the Securities and Exchange Commission on January 29, 2026, disclosing a material event.
Dare Bioscience, Inc.'s stock currently trades at $1.90 with a market capitalization of $19.8M. The Healthcare company's stock moved following the disclosure.